Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Comparison between en face structural spectral-domain and swept-source OCT angiographic scans for the detection of persistent choroidal hypertransmission defects in AMD
Author Affiliations & Notes
  • Gissel Herrera
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Mengxi Shen
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Omer Trivizki
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Jeremy Liu
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Yingying Shi
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Farhan E. Hiya
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Jianqing Li
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
  • Yuxuan Cheng
    Bioengineering, University of Washington, Seattle, Washington, United States
  • Qinqin Zhang
    Research and Development, Carl Zeiss Meditec Inc, Dublin, California, United States
  • Giovanni Gregori
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Ruikang K Wang
    Bioengineering, University of Washington, Seattle, Washington, United States
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Philip J Rosenfeld
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Gissel Herrera None; Mengxi Shen None; Omer Trivizki None; Jeremy Liu None; Yingying Shi None; Farhan Hiya None; Jianqing Li None; Yuxuan Cheng None; Qinqin Zhang Carl Zeiss Meditec, Code E (Employment); Giovanni Gregori Carl Zeiss Meditec, Code F (Financial Support); Ruikang Wang Carl Zeiss Meditec, Code C (Consultant/Contractor), Carl Zeiss Meditec, Colgate Palmolive Company, Estee Lauder Inc , Code F (Financial Support), US8, 750, 586, US8, 180, 134, US9, 282, 905, US9, 759, 544, US10, 354, 378, US10, 529, 061, Code P (Patent); Philip Rosenfeld Annexon, Apellis, Bayer, Boehringer-Ingelheim, Carl Zeiss Meditec, Chengdu Kanghong Biotech, InflammX, Ocudyne, Regeneron, Unity Biotechnology, Code C (Consultant/Contractor), Alexion, Carl Zeiss Meditec, Gyroscope Therapeutics, Stealth BioTherapeutics, Code F (Financial Support), Apellis, Ocudyne, Valitor, Verana Health, Code I (Personal Financial Interest)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 325. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gissel Herrera, Mengxi Shen, Omer Trivizki, Jeremy Liu, Yingying Shi, Farhan E. Hiya, Jianqing Li, Yuxuan Cheng, Qinqin Zhang, Giovanni Gregori, Ruikang K Wang, Philip J Rosenfeld; Comparison between en face structural spectral-domain and swept-source OCT angiographic scans for the detection of persistent choroidal hypertransmission defects in AMD. Invest. Ophthalmol. Vis. Sci. 2023;64(8):325.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Persistent choroidal hypertransmission defects (hyperTDs) were first described using en face spectral-domain OCT (SD-OCT) structural scans and subsequently studied using swept-source OCT angiography (SS-OCTA) scans. SD-OCT angiography (SD-OCTA) scans had not been previously used for the detection of these hyperTDs. To determine if SD-OCTA structural scans could provide similar results to SS-OCTA structural scans for the detection and measurement of hyperTDs, we analyzed same day images of the same patient on both instruments.

Methods : In this prospective OCT study, patients with age-related macular degeneration (AMD) and hyperTDs underwent SD-OCTA and SS-OCTA imaging at the same visit using the 6X6 mm scan patterns. The SD-OCTA scan consisted of 350 A-scans per B-scans and 350 B-scans along the y-axis, each B-scan repeated twice at each position. The SS-OCTA scan consisted of 500 A-scans per B-scans and 500 B-scans along the y-axis, each B-scan repeated twice at each position. En face images were generated from a slab with boundaries extending 64 to 400 µm beneath Bruch’s membrane. Two graders independently evaluated all en face structural images for the presence of persistent hyperTDs, which are defined as having a greatest linear dimension of ≥ 250 µm. At each visit, the number and area of all hyperTDs were obtained from both SD-OCTA and SS-OCTA scans. The square root of the total areas of the hyperTDs were compared.

Results : A total of 40 eyes from 32 subjects had SD-OCTA and SS-OCTA images taken on the same day. The number and total areas of hyperTDs for the two modalities were highly correlated, with correlation coefficients of 0.971 and 0.999, respectively. The mean number of hyperTDs were 4.2 ± 3.1 for the SD-OCTA and 4.5 ± 3.3 for the SS-OCTA scans, while the mean square root of the total hyperTD areas were 1.13 ± 0.63 mm for the SD-OCTA and 1.17 ± 0.65 mm for the SS-OCTA scans. Because of the strong correlation the small differences between the two scan patterns were statistically significant (P values <0.05), however, they should not be considered clinically significant.

Conclusions : The number and size of hyperTDs were strongly correlated between the SD-OCTA and SS-OCTA scans. This suggests that a single SD-OCTA scan pattern can be used for both structural and angiographic assessment of disease progression in AMD.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×